Olivia Tort

Olivia Tort

Auto-generated profile, based on publicly available information

Olivia Tort

Cell Compartments and Signaling Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Science
Verified
Journal Article
Closed access
MBMarta Bosch
Marta Bosch
MSMiguel Sanchez-Alvarez
Miguel Sanchez-Alvarez
AFAlba Fajardo
Alba Fajardo
RKRonan Kapetanovic
Ronan Kapetanovic
BSBernhard Steiner
Bernhard Steiner
APAlbert Pol
Albert Pol
Cells drop a bomb on pathogens: Lipid droplets (LDs) accumulate in cells to serve as lipid storage organelles. They are also an attractive source of nutrients for many pathogens. Bosch et al. show that various proteins involved in innate immunity form complexes on LDs in response to bacterial lipopolysaccharide (see the Perspective by Green). Upon activation, LDs became physically uncoupled from mitochondria, driving a shift in cells from oxidative phosphorylation to aerobic glycolysis. This work highlights the ability of LDs both to kill pathogens directly and to establish a metabolic environment conducive to host defense. This may inform future antimicrobial strategies in the age of antibiotic resistance. Science , this issue p. eaay8085 ; see also p. 294

1 September 2014 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CRCecilia Rocha
Cecilia Rocha
LPLaura Papon
Laura Papon
WCWulfran Cacheux
Wulfran Cacheux
PSPatricia Marques Sousa
Patricia Marques Sousa
VLValeria Lascano
Valeria Lascano
CJCarsten Janke
Carsten Janke
TTLL3 and TTLL8 are tubulin glycine ligases catalyzing posttranslational glycylation of microtubules. We show here for the first time that these enzymes are required for robust formation of primary cilia. We further discover the existence of primary cilia in colon and demonstrate that TTLL3 is the only glycylase in this organ. As a consequence, colon epithelium shows a reduced number of primary cilia accompanied by an increased rate of cell division in TTLL3‐knockout mice. Strikingly, higher proliferation is compensated by faster tissue turnover in normal colon. In a mouse model for tumorigenesis, lack of TTLL3 strongly promotes tumor development. We further demonstrate that decreased levels of TTLL3 expression are linked to the development of human colorectal carcinomas. Thus, we have uncovered a novel role for tubulin glycylation in primary cilia maintenance, which controls cell proliferation of colon epithelial cells and plays an essential role in colon cancer development. ![][1] This study reports first evidence for tubulin glycylation to affect the establishment and maintenance of primary cilia. Functional abrogation of tubulin glycine ligases impacts cell proliferation and tumor onset. The EMBO Journal (2014) 33: 2247–2260 [1]: pending:yes

1 October 2014 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
OTOlivia Tort
Olivia Tort
Sebastian TancoSebastian Tanco
Sebastian Tanco
CRCecilia Rocha
Cecilia Rocha
IBIvan Bieche
Ivan Bieche
CSCecilia Seixas
Cecilia Seixas
CJCarsten Janke
Carsten Janke
The posttranslational modification of carboxy-terminal tails of tubulin plays an important role in the regulation of the microtubule cytoskeleton. Enzymes responsible for deglutamylating tubulin have been discovered within a novel family of mammalian cytosolic carboxypeptidases. The discovery of these enzymes also revealed the existence of a range of other substrates that are enzymatically deglutamylated. Only four of six mammalian cytosolic carboxypeptidases had been enzymatically characterized. Here we complete the functional characterization of this protein family by demonstrating that CCP2 and CCP3 are deglutamylases, with CCP3 being able to hydrolyze aspartic acids with similar efficiency. Deaspartylation is a novel posttranslational modification that could, in conjunction with deglutamylation, broaden the range of potential substrates that undergo carboxy-terminal processing. In addition, we show that CCP2 and CCP3 are highly regulated proteins confined to ciliated tissues. The characterization of two novel enzymes for carboxy-terminal protein modification provides novel insights into the broadness of this barely studied process.

15 February 2016 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
CAChrystelle Aillaud
Chrystelle Aillaud
CBChristophe Bosc
Christophe Bosc
YSYasmina Saoudi
Yasmina Saoudi
EDEric Denarier
Eric Denarier
LPLeticia Peris
Leticia Peris
MMMarie-Jo Moutin
Marie-Jo Moutin
Cellular α-tubulin can bear various carboxy-terminal sequences: full-length tubulin arising from gene neosynthesis is tyrosinated, and two truncated variants, corresponding to detyrosinated and Δ2 α‑tubulin, result from the sequential cleavage of one or two C-terminal residues, respectively. Here, by using a novel antibody named 3EG that is highly specific to the –EEEG C-terminal sequence, we demonstrate the occurrence in neuronal tissues of a new αΔ3‑tubulin variant corresponding to α1A/B‑tubulin deleted of its last three residues (EEY). αΔ3‑tubulin has a specific distribution pattern: its quantity in the brain is similar to that of αΔ2-tubulin around birth but is much lower in adult tissue. This truncated α1A/B-tubulin variant can be generated from αΔ2-tubulin by the deglutamylases CCP1, CCP4, CCP5, and CCP6 but not by CCP2 and CCP3. Moreover, using 3EG antibody, we identify a C‑terminally truncated β-tubulin form with the same –EEEG C-terminal sequence. Using mass spectrometry, we demonstrate that β2A/B-tubulin is modified by truncation of the four C-terminal residues (EDEA). We show that this newly identified βΔ4-tubulin is ubiquitously present in cells and tissues and that its level is constant throughout the cell cycle. These new C-terminally truncated α- and β-tubulin variants, both ending with –EEEG sequence, are expected to regulate microtubule physiology. Of interest, the αΔ3-tubulin seems to be related to dynamic microtubules, resembling tyrosinated-tubulin rather than the other truncated variants, and may have critical function(s) in neuronal development.

19 October 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MOMónica Rodríguez de la Vega Otazo
Mónica Rodríguez de la Vega Otazo
JLJulia Lorenzo
Julia Lorenzo
OTOlivia Tort
Olivia Tort
Francesc Xavier AvilesFrancesc Xavier Aviles
Francesc Xavier Aviles
JBJosé M. Bautista
José M. Bautista
Recent experimental data indicating axonal regeneration, axogenesis, dendritogenesis, and ciliary axoneme assembly and wellness have linked the role of cytosolic metallocarboxypeptidase 1 (CCP1/AGTPBP1/Nna1) to the microtubule network. In addition, 5 of the 6 mammalian ccp genes have been shown to participate in post‐translational modifications of tubulin, which occur in the microtubules of neurons, mitotic spindles, cilia, and basal bodies. Here, we compile evidence for the idea that the occurrence of CCPs strongly correlates with the presence of cilia, suggesting that CCP functions might be primarily related to cilia and basal bodies (CBBs). In agreement with this hypothesis, CCPs were localized in centrioles, basal bodies, and mitotic spindles in HeLa cells by confocal microscopy. By reconstructing the evolutionary history of CCPs, we show their presence in the last eukaryotic common ancestor and relate each group of CCP orthologs to specific roles in CBBs. The clues presented in this study suggest that during the evolution of eukaryotes, mechanisms mediated by CCPs through tubulin post‐translational modifications controlling assembly, trafficking, and signaling in the microtubules, were transferred from cilia to cell and axon microtubules.—Rodríguez de la Vega Otazo, M., Lorenzo, J., Tort, O., Avilés, F. X., Bautista, J. M. Functional segregation and emerging role of cilia‐related cytosolic carboxypeptidases (CCPs). FASEB J. 27, 424–431 (2013). www.fasebj.org

5 April 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
LGLorena García-Fernández
Lorena García-Fernández
Javier Garcia-PardoJavier Garcia-Pardo
Javier Garcia-Pardo
OTOlivia Tort
Olivia Tort
IPIan Prior
Ian Prior
MBMathias Brust
Mathias Brust
VPVictor Puntes
Victor Puntes
Gold nanoparticles (17 nm) have been functionalized with the antiangiogenic monoclonal antibody drug Cetuximab at a well-defined orientation and coverage density of antibodies. Functionalization has been carried out through site-directed chemistry via the selective oxidation of the carbohydrate moiety of antibodies linked to a thiolated hydrazide. A431 tumor cells have been exposed to these conjugates for in vitro evaluation of their effects. In addition to epithelial growth factor receptor blocking, trafficking and signaling alterations were also observed. Thus, the blocking effects of Cetuximab were increased and sustained for a longer time when associated with the nanoparticles. Enhancing antibody therapy effects by decreasing the needed dose and prolonging its effect by avoiding receptor recycling may serve to obtain increased therapeutic benefits for immunotherapy.